Paroxetine rapidly modulates the expression of brain-derived neurotrophic factor mRNA and protein in a human glioblastoma-astrocytoma cell line

Pharmacology

Volumn 87, Issue 1-2, 2011, Pages 5-10

  Angelucci, Francesco ^a   Croce, Nicoletta ^b   Spalletta, Gianfranco ^a   Dinallo, Vincenzo ^b   Gravina, Paolo ^b   Bossù, Paola ^a   Federici, Giorgio ^b   Caltagirone, Carlo ^a,c   Bernardini, Sergio ^b  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^b Department of Internal Medicine ^*  (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Antidepressant drugs; Brain derived neurotrophic factor; Depression; Glial cells; miR 30a 5p; Paroxetine

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; MESSENGER RNA; MICRORNA; PAROXETINE;

ARTICLE; ASTROCYTOMA CELL; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; INCUBATION TIME; POSTTRANSCRIPTIONAL GENE SILENCING; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIDEPRESSIVE AGENTS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL LINE; CELL SURVIVAL; GENE EXPRESSION REGULATION; HUMANS; MICRORNAS; NEUROGLIA; OSMOLAR CONCENTRATION; PAROXETINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEROTONIN UPTAKE INHIBITORS; TIME FACTORS; UP-REGULATION;

EID: 78650230853     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000322528     Document Type: Article

References (38)

1. Leonard BE: Stress, norepinephrine and depression. J Psychiatry Neurosci 2001; 26:S11-S16. (Pubitemid 34218789)
2. Hyttel J: Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs). Int Clin Psychopharmacol 1994; 9: 19-26. (Pubitemid 24107713)
3. Berton O, Nestler EJ: New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci 2006; 7: 137-151. (Pubitemid 43151600)
4. Castren E: Is mood chemistry? Nat Rev Neurosci 2005; 6: 241-246. (Pubitemid 40342418)
5. Duman RS, Monteggia LM: A neurotrophic model for stress-related mood disorder. Biol Psychiatry 2006; 59: 1116-1127.
6. 2003; 301: 805-809. (Pubitemid 36962615)
7. Tongiorgi E: Activity-dependent expression of brain-derived neurotrophic factor in dendrites: facts and open questions. Neurosci Res 2008; 61: 335-346.
8. Bramham CR: Control of synaptic consolidation in the dentate gyrus: mechanisms, functions, and therapeutic implications. Prog Brain Res 2007; 163: 453-471. (Pubitemid 47321449)
9. Altar CA: Neurotrophins and depression. Trends Pharmacol Sci 1999; 20: 59-61. (Pubitemid 29323957)
10. Djalali S, Höltje M, Grosse G, Rothe T, Stroh T, Grosse J, Deng DR, Hellweg R, Grantyn R, Hörtnagl H, Ahnert-Hilger G: Effects of brain-derived neurotrophic factor (BDNF) on glial cells and serotonergic neurones during development. J Neurochem 2005; 92: 616-627. (Pubitemid 40189464)
11. Luellen BA, Bianco LE, Schneider LM, Andrews AM: Reduced brain-derived neurotrophic factor is associated with a loss of serotonergic innervation in the hippocampus of aging mice. Genes Brain Behav 2007; 6: 482-490. (Pubitemid 47024961)
12. Sen S, Duman R, Sanacora G: Serum brainderived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol Psychiatry 2008; 64: 527-532.
13. Nibuya M, Morinobu S, Duman RS: Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatment. J Neurosci 1995; 15: 7539-7547.
14. Tardito D, Perez J, Tiraboschi E, Musazzi L, Racagni G, Popoli M: Signaling pathways regulating gene expression, neuroplasticity, and neurotrophic mechanisms in the action of antidepressants: a critical overview. Pharmacol Rev 2006; 58: 115-134.
15. Tsankova NM, Berton O, Renthal W, Kumar A, Neve RL, Nestler EJ: Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neurosci 2006; 9: 519-525.
16. Monteggia LM, Barrot M, Powell CM, Berton O, Galanis V, Gemelli T, Meuth S, Nagy A, Greene RW, Nestler EJ: Essential role of brain-derived neurotrophic factor in adult hippocampal function. Proc Natl Acad Sci USA 2004; 101: 10827-10832. (Pubitemid 38955827)
17. Saarelainen T, Hendolin P, Lucas G, Koponen E, Sairanen M, MacDonald E, Agerman K, Haapasalo A, Nawa H, Aloyz R, Ernfors P, Castrén E: Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant- induced behavioral effects. J Neurosci 2003; 23: 349-357. (Pubitemid 36050437)
18. Chen B, Dowlatshahi D, MacQueen GM, Wang JF, Young LT: Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry 2001; 50: 260-265. (Pubitemid 32778442)
19. Hutchinson AJ, Chou CL, Israel DD, Xu W, Regan JW: Activation of EP 2 prostanoid receptors in human glial cell lines stimulates the secretion of BDNF. Neurochem Int 2009; 54: 439-446.
20. Sato Y, Chin Y, Kato T, Tanaka Y, Tozuka Y, Mase M, Ageyama N, Ono F, Terao K, Yoshikawa Y, Hisatsune T: White matter activated glial cells produce BDNF in a stroke model of monkeys. Neurosci Res 2009; 65: 71-78.
21. Ongür D, Drevets WC, Price JL: Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci USA 1998; 95: 13290-13295. (Pubitemid 28509564)
22. Rajkowska G, Miguel-Hidalgo JJ, Wei J, Dilley G, Pittman SD, Meltzer HY, Overholser JC, Roth BL, Stockmeier CA: Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry 1999; 45: 1085-1098. (Pubitemid 29236550)
23. Mellios N, Huang HS, Grigorenko A, Rogaev E, Akbarian S: A set of differentially expressed miRNAs, including miR-30a-5p, act as post-transcriptional inhibitors of BDNF in prefrontal cortex. Hum Mol Genet 2008; 17: 3030-3042.
24. Zhao S, Fernald RD: Comprehensive algorithm for quantitative real-time polymerase chain reaction. J Comput Biol 2005; 12: 1045-1062.
25. Koponen E, Rantamäki T, Voikar V, Saarelainen T, MacDonald E, Castrén E: Enhanced BDNF signaling is associated with an antidepressant-like behavioral response and changes in brain monoamines. Cell Mol Neurobiol 2005; 25: 973-980. (Pubitemid 43154821)
26. Yoshimura R, Mitoma M, Sugita A, Hori H, Okamoto T, Umene W, Ueda N, Nakamura J: Effects of paroxetine or milnacipran on serum brain-derived neurotrophic factor in depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31: 1034-1037. (Pubitemid 46824019)
27. Deltheil T, Guiard BP, Cerdan J, David DJ, Tanaka KF, Repérant C, Guilloux JP, Coudoré F, Hen R, Gardier AM: Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice. Neuropharmacology 2008; 55: 1006-1014.
28. Aydemir O, Deveci A, Taneli F: The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29: 261-265. (Pubitemid 40202912)
29. Lee HY, Kim YK: Plasma brain-derived neurotrophic factor as a peripheral marker for the action mechanism of antidepressants. Neuropsychobiology 2008; 57: 194-199.
30. Elkabes S, Di Cicco-Bloom E, Black I: Brain microglia/macrophages express neurotrophins that selectively regulate microglial proliferation and function. J Neurosci 1996; 16: 2508-2521. (Pubitemid 26122673)
31. Sawada M, Sawada H, Nagatsu T: Effects of aging on neuroprotective and neurotoxic properties of microglia in neurodegenerative diseases. Neurodegener Dis 2008; 5: 254-256. (Pubitemid 351347865)
32. Batchelor PE, Liberatore GT, Wong JY, Porritt MJ, Frerichs F, Donnan GA, Howells DW: Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor. J Neurosci 1999; 19: 1708-1716. (Pubitemid 29094189)
33. Marks DM, Park MH, Ham BJ, Han C, Patkar AA, Masand PS, Pae CU: Paroxetine: safety and tolerability issues. Expert Opin Drug Saf 2008; 7: 783-794.
34. Pae CU, Patkar AA: Paroxetine: current status in psychiatry. Expert Rev Neurother 2007; 7: 107-120. (Pubitemid 46434161)
35. Bowley MP, Drevets WC, Ongür D, Price JL: Low glial numbers in the amygdala in major depressive disorder. Biol Psychiatry 2002; 52: 404-412. (Pubitemid 35266731)
36. Rajkowska G: Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biol Psychiatry 2000; 48: 766-777.
37. Müller MB, Lucassen PJ, Yassouridis A, Hoogendijk WJ, Holsboer F, Swaab DF: Neither major depression nor glucocorticoid treatment affects the cellular integrity of the human hippocampus. Eur J Neurosci 2001; 14: 1603-1612. (Pubitemid 35478029)
38. Liu Q, Li B, Zhu HY, Wang YQ, Yu J, Wu GC: Clomipramine treatment reversed the glial pathology in a chronic unpredictable stressinduced rat model of depression. Eur Neuropsychopharmacol 2009; 19: 796-805.